Rankings
▼
Calendar
INVA Q2 2018 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$67M
+14.6% YoY
Gross Profit
$67M
100.0% margin
Operating Income
$63M
93.4% margin
Net Income
$55M
81.4% margin
EPS (Diluted)
$0.49
QoQ Revenue Growth
+28.1%
Cash Flow
Operating Cash Flow
$52M
Free Cash Flow
$52M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$339M
Total Liabilities
$494M
Stockholders' Equity
-$157M
Cash & Equivalents
$87M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$67M
$59M
+14.6%
Gross Profit
$67M
$58M
+15.2%
Operating Income
$63M
$48M
+31.0%
Net Income
$55M
$35M
+55.4%
← FY 2018
All Quarters
Q3 2018 →